Kelly A. Conway
- Neurology top 0.1%
- Parkinson's Disease Mechanisms and Treatments 8
- Neurological disorders and treatments 5
- Neurological diseases and metabolism 3
- Neurology top 0.5%
- Parkinson's Disease Mechanisms and Treatments 8
- Neurological disorders and treatments 5
- Neurological diseases and metabolism 3
- Physiology top 0.5%
- Alzheimer's disease research and treatments 9
- Cellular and Molecular Neuroscience top 0.5%
- Nuclear Receptors and Signaling 2
- Cell Biology top 2%
-
- Computational Drug Discovery Methods 3
-
- Cholinesterase and Neurodegenerative Diseases 3
-
- Protein Structure and Dynamics 2
- Co-authors
- Peter T. LansburyJames D. HarperJean‐Christophe RochetTomas T. DingPaul H. WeinrebRobert M. BieganskiRobin E. WilliamsonSeung‐Jae Lee
- Partner nations
- United States
In The Last Decade
Kelly A. Conway
16 papers receiving 5.9k citations
Hit Papers
Peers
Comparison fields: 5 of 106
- Neurology 4.4k
- Neurology 917
- Physiology 2.7k
- Cellular and Molecular Neuroscience 1.9k
- Cell Biology 627
Countries citing papers authored by Kelly A. Conway
This map shows the geographic impact of Kelly A. Conway's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelly A. Conway with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelly A. Conway more than expected).
Fields of papers citing papers by Kelly A. Conway
This network shows the impact of papers produced by Kelly A. Conway. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelly A. Conway. The network helps show where Kelly A. Conway may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kelly A. Conway, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 8 | |
| 2 | 2019 | 0 | |
| 3 | 2018 | 8 | |
| 4 | 2017 | 1 | |
| 5 | 2010 | 21 | |
| 6 | 2007 | 8 | |
| 7 | 2004 | 149 | |
| 8 | 2004 | 5 | |
| 9 | 2003 | 34 | |
| 10 | 2003 | 8 | |
| 11 | 2002 | 19 | |
| 12 | Kinetic Stabilization of the α-Synuclein Protofibril by a Dopamine-α-Synuclein Adductbreakdown → | 2001 | 921 |
| 13 | 2000 | 179 | |
| 14 | Acceleration of oligomerization, not fibrillization, is a shared property of both α-synuclein mutations linked to early-onset Parkinson's disease: Implications for pathogenesis and therapybreakdown → | 2000 | 1269 |
| 15 | Fibrils Formed in Vitro from α-Synuclein and Two Mutant Forms Linked to Parkinson's Disease are Typical Amyloidbreakdown → | 2000 | 655 |
| 16 | 2000 | 186 | |
| 17 | Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson diseasebreakdown → | 1998 | 1257 |
| 18 | NACP, A Protein Implicated in Alzheimer's Disease and Learning, Is Natively Unfoldedbreakdown → | 1996 | 1241 |
About Kelly A. Conway
Kelly A. Conway is a scholar working on Neurology, Neurology, Physiology, Pharmacology and Cellular and Molecular Neuroscience, having authored 18 papers that have together received 6.0k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (9 papers), Parkinson's Disease Mechanisms and Treatments (8 papers), Neurological disorders and treatments (5 papers), Neurological diseases and metabolism (3 papers), Computational Drug Discovery Methods (3 papers), Cholinesterase and Neurodegenerative Diseases (3 papers), Protein Structure and Dynamics (2 papers) and Nuclear Receptors and Signaling (2 papers). The work is most often cited by research in Neurology (4.4k citations), Neurology (917 citations), Physiology (2.7k citations), Cellular and Molecular Neuroscience (1.9k citations) and Cell Biology (627 citations). Kelly A. Conway has collaborated with scholars based in United States. Frequent co-authors include Peter T. Lansbury, James D. Harper, Jean‐Christophe Rochet, Tomas T. Ding, Paul H. Weinreb, Robert M. Bieganski, Robin E. Williamson, Seung‐Jae Lee, Tiago F. Outeiro and Michael J. Volles. Their work appears in journals such as Biochemistry, Alzheimer s & Dementia, SLAS DISCOVERY, Nature Medicine and Bioorganic & Medicinal Chemistry Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.